Spots Global Cancer Trial Database for A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy
Official Title: A Multicenter, Randomized, Open-label Study of AND017 for the Treatment of Anemia of Cancer in Patients Not Receiving Chemotherapy
Study ID: NCT06075043
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to determine the safety and efficacy of various doses of AND017 after 6 weeks of treatment in subjects with anemia of cancer who are not receiving chemotherapy.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Yusha Zhu, MD, PhD
Affiliation: Kind Pharmaceuticals LLC
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
